2023 annual financial data
Innate Pharma S.A. - American Depositary Shares 2023 Operating margin
Innate Pharma S.A. - American Depositary Shares 2023 operating margin with veri…
Direct answer
Operating margin was -24.41%.
Operating income was -12,669,000 EUR and net income was -7,570,000 EUR.
Operating cash flow was -32,558,000 EUR.
Get free Innate Pharma S.A. - American Depositary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51,901,000 EUR
- Operating income
- -12,669,000 EUR
- Net income
- -7,570,000 EUR
- Operating cash flow
- -32,558,000 EUR
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Innate Pharma S.A. - American Depositary Shares financial years